Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

The Ark 2 trailer that dropped at E3 2022 though is captured in Unreal Engine 5 and looks utterly stunning. Although it's not gameplay, it sets the tone for the game's storyline, which takes place ...

With that in mind, here are all the rumors we've heard about the Nintendo Switch 2 and what we’d like to see. This original rumor suggested that Nintendo had moved the release date of its next ...

We could be just hours away from the highly anticipated reveal of the Switch 2. On January 13, 2025, Nate the Hate, an industry insider with a decent track record, claimed that Nintendo is ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan ...

NLRP3 is a member of a family of proteins known as inflammasome receptors and is a key component ... of pro-inflammatory cytokines like interleukin-1 beta and interleukin-18, and has attracted ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

NK Cells Expressing Interleukin-21 Show Promising Antitumor ... Kill Glioblastoma Cells in Newly Discovered Brain Pathway Aug. 2, 2024 — A new pathway that is used by cancer cells to infiltrate ...

I’m psyched for the movie,” said Tomlison. At first The Batman – Part 2 was delayed to October 2, 2026 but at the end of 2024, it was pushed back another 12 months. It’s now set for ...